January 2026
We are pleased to announce that the Consortium Meeting with all partners took place on January 29, 2026. The meeting was a great success, marked by excellent collaboration and fruitful discussions. We would like to thank all partners for their outstanding cooperation and valuable contributions. We look forward to our continued successful partnership and further progress together.
January 2026 - Happy New Year!
We wish all involved TRACE-study-teams and partners a Happy New Year and are looking forward to the New Year 2026 with continued excellent cooperation between all participating study-teams, further recruitment and progress of the project.
December 2025 - Merry Christmas
At the end of the year 2025, we are happy about our project achievements. The TRACE study is advancing due to great effort and teamwork of all our partners! Thank you very much to everyone involved.
October 2025 - Finally out now!
We’re excited to announce that our innovative strategies for setting up the first multinational placebo-controlled Phase III cell therapy trial — built on a decentralized, multinational academic GMP-manufacturing network — are now publicly accessible!
Discover how we overcame regulatory, logistical and manufacturing challenges here.
October 2025 - New Website launched for TRACE study
In light of the recent change in the sponsor of our ongoing clinical trial, TRACE, we are pleased to announce the launch of a newly redesigned website. The updated homepage continues to offer a more user-friendly experience, with enhanced navigation and additional resources for participants, sites and all interested parties.
Our goal remains to make all relevant information accessible and to ensure clear communication throughout the entire study process. We invite you to explore the new website and stay up-to-date with the latest developments.
Visit the new site at: https://www.uniklinik-freiburg.de/trace-study.html
We thank all sites, participants, members of Consortial Agreement and all involved persons for their continued involvement and support.
May 2025 - Sponsor change at TRACE study
We would like to inform our partners, participants, and the broader clinical research community that there has been a change in the sponsor of our ongoing clinical trial "TRACE". The new sponsor, Medical Center - University of Freiburg, will now oversee the study's progress and ensure its continuation according to the highest standards of clinical research.
This change does not affect the safety or the integrity of the trial. All participants will continue to receive the same high level of care. We are committed to maintaining transparency and will keep all involved persons updated with any further developments.
For more information or any questions regarding this transition, please do not hesitate to contact us at kjk.trace-study@uniklinik-freiburg.de
Thank you for your continued support and participation.
06.04.2023
Shortly before Easter we have some great news:
We can welcome another clinical site in Spain to our TRACE Study:
University Hospital La Paz, Institute for Health Research in Madrid is open for patient recruitment!
With this fantastic new update, we would also like to wish you all some happy and sunny Easter days!
22.03.2023
Today we want to inform that another clinical site in France is open for patient recruitment:
Institut d'Hématologie et d'Oncologie Pédiatrique (IHOPs) in Lyon
We are happy to welcome them to our TRACE Study Team!
17.03.2023
Today we are happy to report that our team continues to grow and still another clinical site is participating in our TRACE Study:
University Hospital Würzburg,
Department of Pediatric Hematology, Oncology and Stem cell transplantation
We are looking forwrd to the start of patient recruitment very soon and would like to warmly welcome them to our TRACE Study Team!
10.03.2023
At the end of this week and for a happy start to the weekend, we would like to welcome another site in Germany to our TRACE study:
University Hospital Regensburg,
Department of Pediatric Hematology, Oncology and Stem cell transplantation
Soon, recruitment will start here as well. Welcome to our TRACE Study Team!
28.02.2023
Some good news at the beginning of the week:
A new clinical site in Germany is participating in our TRACE Study:
Medical Center - University of Freiburg
Deparment of Pediatric Hematology, Oncology and Stem cell transplantation
We warmly welcome them to our TRACE study and we're looking forward to start patient recruitment very soon!
22.02.2023
A few weeks ago, we got to visit our new consortium partners in Barcelona! It was an amazing kick-off meeting in Spain with great participation from the GMP manufacturer at Banc de Sang i Teixits and great pariticipation from the Spanish clinical trial sites in Sevilla, Madrid and Valencia.
We´re looking forward to the next steps in our collaboration!
21.12.20222
At the end of this challenging year 2022, we are happe about our project achievements. The TRACE study is advancing due to great effort and teamwork of all our partners!
We are lookin forward to the New Year 2023 with further patient recruitment and progress of the project.
10.11.2022
TRACE Study was initiated at three new clinical sites in SPAIN:
Vall d'Hebron Institute of Oncology in Barcelona,
Virgen del Rocío University Hospital in Sevilla and
La Fe University and Polytechnic Hospital in Valencia.
01.09.2022
Spain was successfully included as a new country in the TRACE study, the project partner and national coordinator is located at Vall d'Hebron Institute of Oncology (VHIO) in collaboration with Banc de Sang i Teixits (BST) in Barcelona.
23.06.2022
Another site in Paris is participating in the TRACE study: Hôpital Necker Enfants malades in Paris, France (FR) is open for patient inclusion.
09.05.2022
We are happy to annouce that TRACE study was initiated at another clinical site in France: Hôpital Pitié-Salpêtrière in Paris (FR) will be ready to recruit patients very soon.
11.01.2022
We are starting the new year with good news! TRACE study initiated its third clinical site in France. Hôpital universitaire Robert-Debré in Paris (FR) will be ready to recruit patients very soon.
23.11.2021
Today we held our Annual Meeting with the TRACE Consortium. Due to the ongoing COVID-19 pandemic, this year's meeting was an online meeting, once again. Despite these circumstances, important topics could be discussed and lively discussions took place.
We would like to thank the TRACE Consortium for a successful year 2021 and are looking forward to the next year!
03.11.2021
The second site in France is open and ready to recruit patients at University Hospital in Lille, Centre Hospitalier Universitaire, CHU de Lille (FR).
26.10.2021
Another clinical site in Germany joined TRACE and is active and open for recruitment at University Children's Hospital in Essen, Klinik für Kinderheilkunde III, UK Essen (DE).
15.10.2021
We are pleased to announce that there is one more clinical site in Germany active and open for recruitment at University Hospital in Dresden, Technische Universität Dresden (DE).
24.08.2021
We would like to announce that Clinic and Polyclinic for Hematology, Cell Therapy and Hemostaseology at University Hospital Leipzig (DE) joined our study.
17.08.2021
We are happy to welcome an additional initiated site in Belgium at University Hospital in Leuven, Universitaire Ziekenhuizen, UZ Leuven (BE).
10.08.2021
We are happy to announce that our study is now open for recruitment in Italy and France. Patients can therefore be enrolled into TRACE study in five European countries:
Germany, Netherlands, Belgium, Italy and France
19.07.2021
TRACE study was initiated in Italy. The first initiation was performed at our Consortiumg partner from L'Ospedale Pediatrico Bambino Gesù in Rome (IT).
12.07.2021
Another clinical site is active and open for recruitment in Belgium at the University Hospital in Brussels, Universitair Ziekenhuis, UZ Brussel (BE).
05.07.2021
The first initiation of TRACE was performed in France. Welcome to our Consortium partner from Nancy University Hospital, CHRU de Nancy (FR).
24.06.2021
Another site in Germany is active and open for recruitment at Hannover Medical Schoool, MHH (DE).
17.06.2021
The Consortium partner from Ghent Universal Hospital, UZG (BE) has been activated for the study. The clinical site is initiated and open for patient recuitment and the manufacturing site is ready for production of T-cell products.
08.06.2021
We welcome Institut Jules Bordet in Brussels (BE) to our study, which is now open for recruitment in Belgium.
17.05.2021
Growing number of sites: another site in Germany was initiated at University Children's Hospital Tübingen (DE).
10.05.2021
We gladly announce that our study is now open for recruitment in a third country, Belgium. The first site that was initiated here is Centre Hospitalier Universitaire (CHU) de Liège (BE).
03.05.2021
We are happy to announce that we opened another site in Germany at Universitätsklinikum Würzburg (DE).
07.04.2021
We are happy to welcome an additional initiated site LMU Klinikum München, Med. Klinik III (DE)
18.12.2020
Gorwing numbers of active sites:
Leiden University Medical Centre (NL)
Charité Berlin (DE)
Klinikum rechts der Isar - Technische Universität München (DE)
Universitätsklinikum Düsseldorf (DE)
LMU Klinikum München, Dr. von Hauner Children's Hospital (DE)
12.11.2020
Virtual Annual Meeting
04.08.2020
5 CAs approvals completed:
the Netherlands, France, Belgium, Italy and Germany
20.09. - 21.09.20219
Annual Meeting
Rome, ITALY
01.02. - 02.02.2018
Kick-off Meeting
Eibsee, GERMANY
01.01.2018
Start of the TRACE Project